| Phase 1 | 2 | |
| Phase 1/2 | 1 | |
| Phase 2 | 1 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06538480 | Zopa Retreatment and Vector Shedding in Adults With RRP | Recurrent Respiratory Papillomatosis | Recruiting | 2025-12-15 |
| Phase 2 | ||||
| NCT06157151 | PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic… | Cervical Cancer | Recruiting | 2026-04-23 |
| Phase 1/2 | ||||
| NCT04724980 | Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis | Recurrent Respiratory Papillomatosis | Active, Not Recruiting | 2025-06-11 |
| Phase 1 | ||||
| NCT03907527 | Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced… | Platinum-Resistant Fallopian Tube Carcinoma | Active, Not Recruiting | 2024-11-08 |
| NCT03927261 | PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD… | Acute Myeloid Leukemia | Active, Not Recruiting | 2024-11-08 |
Acute Myeloid Leukemia (AML) (1) · Cervical Cancer (1) · Leukemia (1) · Myelodysplastic Syndromes (MDS) (1) · Ovarian Cancer (1)